Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

PaperCitations, authors & open-access status

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 56 citations, 2021 year and closed oa status.

56
Citations
2021
Year
closed
OA Status

Related on ScholarIQ

Michael Friedländer
Author
Giovanni Scambia
Author
Carol Aghajanian
Author
Amit M. Oza
Author
Nicoletta Colombo
Author
The Lancet Oncology
Journal
470M+ articles · free account